Jeffrey Berger, MD: Antithrombotic Strategy Following TAVR
TAVR has revolutionized treatment for aortic stenosis but we are still learning more about how to best manage antithrombotic strategy following this procedure.
Related Articles
AMA, ACR, Others Say Medicare Cuts Will Impact Access to Care
A newly passed bill permits 2.8% Medicare physician payment cuts.
Collaborative HCV Care with Pharmacists Could Address System-Level Treatment Barriers
The success of community-based point-of-diagnosis HCV treatment in the NOW trial was attributable to collaborative care with an integrated pharmacy team.
The Medical Sisterhood: Empower Hour at AAD 2025
Latanya Benjamin, MD, and Lindsay Ackerman, MD, joins The Medical Sisterhood in a live recording at AAD 2025 to discuss advocacy, mentorship, and empowerment.
New ACP Guidelines Recommend Adding Triptan to NSAID or Acetaminophen for Migraines
New ACP migraine guidelines recommend adding a triptan to NSAIDs or acetaminophen for better relief. Combination therapy offers greater pain relief and fewer rescues.
Expert Perspectives: Dermatology’s Top Story to Watch in 2025
A group of 9 experts reflect on what they are looking forward to most in 2025 following the AAD annual meeting.
Subcutaneous Spesolimab Effective for Generalized Pustular Psoriasis Symptoms
These data highlight the potential benefit of continuous treatment with subcutaneous spesolimab for generalized pustular psoriasis (GPP).
Epicutaneous Immunotherapy Shows Favorable Long-Term Safety for Peanut Allergy
The phase 3 REALISE study found EPIT with VP250 had a strong safety profile, with severe adverse events dropping from 9.7% in year 1 to…
Travere Therapeutics Submits sNDA for Sparsentan (Filspari) in FSGS
The submission is supported by results from the phase 3 DUPLEX Study and the phase 2 DUET Study in adult and pediatric patients with FSGS.
New Phase 3 Findings Demonstrate Efficacy of Povorcitinib for HS Treatment
These pivotal phase 3 data on povorcitinib were the results of the STOP-HS clinical trial, with results suggesting both efficacy and safety for hidradenitis suppurativa.
Antibiotics are the Most Common Drugs to Induce Anaphylaxis
A study found ceftriaxone was the most common drug to lead to anaphylaxis in children.